Article Details
Retrieved on: 2021-07-28 19:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer ...
Article found on: www.heraldchronicle.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here